Showing 281-290 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Evaluating the Effectiveness and Safety of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 1 Diabetes | Emory University | Hui Shao | Improving Lives | 01-July-2025 to 30-June-2027 | $599,998.91 |
| Impact of Inflammatory Cytokines on ER-Mitochondria Crosstalk and Proinsulin Folding in Beta Cells | East Tennessee State University | Anoop Arunagiri | Cures | 01-August-2025 to 31-July-2027 | $241,431.00 |
| Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling | Duke University | Rhonda Merwin | Improving Lives | 01-July-2022 to 30-June-2027 | $2,534,224.22 |
| Broad Scope CMC, Non-Clinical, and Regulatory Support | Dark Horse Consulting | Nathan Manley | Cures | 01-September-2025 to 31-December-2026 | $85,000.00 |
| Brown University IND Readiness Gap Analysis | Dark Horse Consulting | Nathan Manley | Cures | 01-June-2025 to 31-December-2025 | $87,770.00 |
| IND Readiness Gap Finding and Risk Assessment (SOW25094) | Dark Horse Consulting | Amanda Mack | Cures | 01-June-2025 to 31-August-2025 | $74,625.00 |
| Type 1 Diabetes Consortium – Core and Prevention Workstream | Critical Path Institute (C-Path) | Sarah David | Cures | 01-July-2022 to 30-June-2025 | $800,270.00 |
| Type 1 Diabetes Consortium – New Onset Workstream | Critical Path Institute (C-Path) | Joseph Hedrick | Cures | 28-October-2022 to 31-December-2025 | $1,132,723.00 |
| A glucose-responsive cannula of insulin delivery | Cornell University | Bo Wang | Improving Lives | 01-March-2023 to 28-February-2025 | $181,628.32 |
| Convergency, LLC Consulting Agreement | Convergency | Larry Soler | Transportfolio | 01-March-2025 to 28-February-2026 | $60,000.00 |